ArticleClinics and practice2026

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports.

Alessandro Guffanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.